Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Nikolaus

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Der Internist|June 28, 2008
[Anti-TNF biologics in the treatment of chronic inflammatory bowel disease]S Nikolaus, S Schreiber
Deutsche Medizinische Wochenschrift (1946)|April 15, 2004
[Molecular mechanisms for the control of life-expectancy]S Nikolaus, S Schreiber
Deutsche Medizinische Wochenschrift (1946)|January 24, 2013
[Treatment of inflammatory bowel disease]S Nikolaus, S Schreiber
Gut|June 9, 1998
Activation of nuclear factor kappa B inflammatory bowel diseaseS Schreiber, S Nikolaus, J Hampe
Hepato-Gastroenterology|February 26, 2000
Immunopharmacology of 5-aminosalicylic acid and of glucocorticoids in the therapy of inflammatory bowel diseaseS Nikolaus, U Fölscn, S Schreiber
Der Internist|July 17, 2014
[Microbiome and nutrition. The way to a future therapy for chronic inflammatory bowel diseases?]S Schreiber, S Nikolaus, P Rosenstiel
Der Internist|April 5, 2005
[Pharmacologic therapy for inflammatory bowel diseases: hopes, disappointments]S Nikolaus, S Schreiber, U R Fölsch
Nuklearmedizin. Nuclear Medicine|December 9, 2014
Focus on GABA(A) receptor function. A comparative analysis of in vivo imaging studies in neuropsychiatric disordersS Nikolaus, H Hautzel, H-W Müller
Neural Plasticity|March 14, 2000
Pretreatment with fragments of substance-P or with cholecystokinin differentially affects recovery from sub-total nigrostriatal 6-hydroxydopamine lesionS Nikolaus, J P Huston, R K Schwarting
Neuroscience Letters|March 24, 2000
Anxiolytic-like effects in rats produced by ventral pallidal injection of both N- and C-terminal fragments of substance PS Nikolaus, J P Huston, R U Hasenöhrl
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Der Internist|June 28, 2008
[Anti-TNF biologics in the treatment of chronic inflammatory bowel disease]S Nikolaus, S Schreiber
Deutsche Medizinische Wochenschrift (1946)|April 15, 2004
[Molecular mechanisms for the control of life-expectancy]S Nikolaus, S Schreiber
Deutsche Medizinische Wochenschrift (1946)|January 24, 2013
[Treatment of inflammatory bowel disease]S Nikolaus, S Schreiber
Gut|June 9, 1998
Activation of nuclear factor kappa B inflammatory bowel diseaseS Schreiber, S Nikolaus, J Hampe
Hepato-Gastroenterology|February 26, 2000
Immunopharmacology of 5-aminosalicylic acid and of glucocorticoids in the therapy of inflammatory bowel diseaseS Nikolaus, U Fölscn, S Schreiber
Der Internist|July 17, 2014
[Microbiome and nutrition. The way to a future therapy for chronic inflammatory bowel diseases?]S Schreiber, S Nikolaus, P Rosenstiel
Der Internist|April 5, 2005
[Pharmacologic therapy for inflammatory bowel diseases: hopes, disappointments]S Nikolaus, S Schreiber, U R Fölsch
Nuklearmedizin. Nuclear Medicine|December 9, 2014
Focus on GABA(A) receptor function. A comparative analysis of in vivo imaging studies in neuropsychiatric disordersS Nikolaus, H Hautzel, H-W Müller
Neural Plasticity|March 14, 2000
Pretreatment with fragments of substance-P or with cholecystokinin differentially affects recovery from sub-total nigrostriatal 6-hydroxydopamine lesionS Nikolaus, J P Huston, R K Schwarting
Neuroscience Letters|March 24, 2000
Anxiolytic-like effects in rats produced by ventral pallidal injection of both N- and C-terminal fragments of substance PS Nikolaus, J P Huston, R U Hasenöhrl
Pageof 6